His main research concerns Prostate cancer, Surgery, Internal medicine, Urology and Prostate-specific antigen. Scott E. Eggener interconnects Biopsy, Radiology and Prostate in the investigation of issues within Prostate cancer. His Biopsy study combines topics from a wide range of disciplines, such as Prostate biopsy and Image-Guided Biopsy.
His Surgery research is multidisciplinary, incorporating elements of Prostatectomy, Kidney cancer, Kidney disease and Metastasis. His studies deal with areas such as Survival rate, Perioperative, Urinary incontinence and Oncology as well as Prostatectomy. His work deals with themes such as Transitional cell carcinoma, Predictive value of tests, Urine cytology, Cytology and Carcinoma, which intersect with Urology.
The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Surgery, Urology and Oncology. His studies in Prostate cancer integrate themes in fields like Biopsy and Prostate. His Prostate study incorporates themes from Ablation, Magnetic resonance imaging, Radiology and Nuclear medicine.
The concepts of his Surgery study are interwoven with issues in Urinary system, Nephrectomy and Cohort. His Positive Surgical Margin research extends to the thematically linked field of Urology. His Prostatectomy study integrates concerns from other disciplines, such as Odds ratio, Urinary incontinence, Radiation therapy and Nomogram.
Scott E. Eggener mostly deals with Prostate cancer, Internal medicine, Oncology, Prostate and Radiology. His study involves Prostatectomy and Prostate-specific antigen, a branch of Prostate cancer. His work carried out in the field of Prostatectomy brings together such families of science as Randomized controlled trial, Logistic regression, Incidence and Urology.
As a part of the same scientific family, Scott E. Eggener mostly works in the field of Internal medicine, focusing on Guideline and, on occasion, Molecular biomarkers and Standard treatment. His work on Adjuvant as part of general Oncology research is frequently linked to Identification, bridging the gap between disciplines. In the subject of general Prostate, his work in Prostate biopsy is often linked to Laser ablation, thereby combining diverse domains of study.
Prostate cancer, Internal medicine, Oncology, Magnetic resonance imaging and Prostatectomy are his primary areas of study. His work on Prostate-specific antigen as part of general Prostate cancer research is often related to Context, thus linking different fields of science. Scott E. Eggener has included themes like Gastroenterology and Guideline in his Internal medicine study.
In his research on the topic of Oncology, Consensus conference and Germline is strongly related with Genetic testing. His biological study deals with issues like Medical physics, which deal with fields such as Radical treatment and Delphi method. His Prostatectomy research incorporates themes from Logistic regression, Cohort and Urology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco.
The New England Journal of Medicine (2018)
POTENCY, CONTINENCE AND COMPLICATIONS IN 3,477 CONSECUTIVE RADICAL RETROPUBIC PROSTATECTOMIES
Shilajit D. Kundu;Kimberly A. Roehl;Scott E. Eggener;Jo Ann V. Antenor.
The Journal of Urology (2004)
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
Scott E. Eggener;Peter T. Scardino;Patrick C. Walsh;Misop Han.
The Journal of Urology (2011)
Focal Therapy for Localized Prostate Cancer: A Critical Appraisal of Rationale and Modalities
Scott E. Eggener;Peter T. Scardino;Peter R. Carroll;Michael J. Zelefsky.
The Journal of Urology (2007)
Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: Recommendations from an International Working Group.
Caroline M. Moore;Veeru Kasivisvanathan;Scott Eggener;Mark Emberton.
European Urology (2013)
The role of SPINK1 in ETS rearrangement-negative prostate cancers.
Scott A. Tomlins;Daniel R. Rhodes;Jianjun Yu;Sooryanarayana Varambally.
Cancer Cell (2008)
Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance.
Ryan K. Berglund;Timothy A. Masterson;Kinjal C. Vora;Scott E. Eggener.
The Journal of Urology (2008)
Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR
Andrew B. Rosenkrantz;Sadhna Verma;Peter Choyke;Steven C. Eberhardt.
The Journal of Urology (2016)
Positive Surgical Margins at Partial Nephrectomy: Predictors and Oncological Outcomes
Ofer Yossepowitch;R. Houston Thompson;Bradley C. Leibovich;Scott E. Eggener.
The Journal of Urology (2008)
Diffusion-Weighted and Dynamic Contrast-Enhanced MRI of Prostate Cancer: Correlation of Quantitative MR Parameters With Gleason Score and Tumor Angiogenesis
Aytekin Oto;Cheng Yang;Arda Kayhan;Maria Tretiakova.
American Journal of Roentgenology (2011)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: